Cointime

  • 最新情報
  • ニュース
  • 通貨
  • Columns
  • イベント
  • Bitcoin $104,516.99 +0.51%
  • Ethereum $2,536.02 -0.45%
  • BNB $657.11 -0.65%
  • Optimism $0.64 -2.45%
  • Arbitrum $0.34 -2.89%
  • Solana $156.42 -1.52%
  • Polygon $0.22 +2.77%
  • Cosmos $4.33 -0.51%
  • Avalanche $20.86 -0.64%
  • Bitcoin $104,516.99 +0.51%
  • Ethereum $2,536.02 -0.45%
  • BNB $657.11 -0.65%
  • Optimism $0.64 -2.45%
  • Arbitrum $0.34 -2.89%
  • Solana $156.42 -1.52%
  • Polygon $0.22 +2.77%
  • Cosmos $4.33 -0.51%
  • Avalanche $20.86 -0.64%
Home / Kala Pharmaceuticals / investors

Kala Pharmaceuticals

company

Investors

Number of Lead Investors
Number of Investors
5
15
Kala Pharmaceuticals is funded by 15 investors. Oxford Finance LLC and Athyrium Capital Management LP are the most recent investors.
Investor Name Lead Investor Funding Round
Oxford Finance LLC Yes Post-IPO Debt
Athyrium Capital Management LP Yes Post-IPO Equity
Longitude Capital Yes Series C
Ysios Capital Yes Series B
CAM Capital - Series C
Lux Capital - Series C
OrbiMed - Series C
Polaris Partners - Series C
RA Capital Management - Series C
Vivo Capital - Series C
Wellington Management - Series C
AbbVie Biotech Ventures - Series B
Crown Venture Fund - Series B
Third Rock Ventures - Series B
Lighthouse Capital Partners - Private Equity(PE)

Contact

Waltham,Massachusetts,United States
1(781) 996-5252
Cointime
Content
  • 最新情報
  • スタートアップ
  • 業界ニュース
  • テクノロジー
  • イベント
Company
  • 会社概要
  • 広告
  • 免責事項
  • © 2023 Cointime. 無断転載禁止
  • プライバシーポリシー
  • 利用規約
Cointime

Recently Searched

Hot Coins

Trending

毎日の必読